To maintain, produce, authenticate and distribute arthropod vectors and associated reagents for the Emerging Infections Resources Program.

To leverage the WHO Global Rotavirus Surveillance Network (GRSN) by using novel technology to achieve a better understanding of the role of enteric pathogens other than rotavirus in childhood diarrhea requiring hospitalization and create the Global Pediatric Diarrheal Surveillance Network (GPDS).

To promote safety and wellness among U.S. travelers through the collection and dissemination of up-to-date and accurate scientific information.

To support the production and qualification of inactivated rotavirus vaccine clinical material.

To honor and recognize important work to promote safe injection practices and patient safety and produce educational materials that raise awareness and highlight the work of the One & Only Campaign.

To support two annual two-day conferences for journalists from media outlets reaching rural, frontier and urban populations to provide training on where to access reliable health information.

To develop a Global Pediatric Norovirus Laboratory Surveillance Network to monitor norovirus strains and provide data critical for decision-making related to norovirus vaccination.

To support Haiti's vaccine distribution efforts as well as water and sanitation improvements in response to the 2021 earthquake.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.

To improve awareness and implementation of respiratory virus prevention, the CDC Foundation will support a coalition that shares information, promotes collaboration and advances CDC goals to strengthen coordination and data-informed strategies.

To assess the impact of the Pneumococcal conjugate vaccine catch up campaign among internally displaced populations in the northern Sahel region of Burkina Faso. This effort will implement and evaluate the impact of changing the pneumococcal conjugate vaccine schedule.

To assist the Ministry of Public Health (MOPH) in establishing a Field Epidemiology Training Program (FETP) in Qatar focused on building its public health workforce capacity.

To evaluate the impact of HPV vaccine and the persistence of HPV antibody among HPV-vaccinated women living with HIV in Botswana.

To support key laboratory systems strengthening interventions for early disease detection, disease monitoring, and laboratory based disease surveillance for priority diseases of public health importance in Lagos, Nigeria.

To increase vaccine confidence and access among those most affected by mpox.

To support CDC with diagnostic development and processing for the global Guinea Worm Eradication Program (GWEP). This project will provide CDC with the laboratory support needed to diagnose possible Guinea worm (GW) specimens submitted by endemic and non-endemic countries and to validate and/or develop novel Guinea worm diagnostic tests.

To evaluate the safety, pharmacokinetics and efficacy of macaque-sized CLIP 3D printed intravaginal rings (IVRs) loaded with the potent antiretroviral Islatravir (EFdA) when administered vaginally to pigtailed macaques.

To help implement the CDC Foundation programs and activities supporting the Targeted Country Assistance portion of the 2022-2025 Partners’ Engagement Framework.

To support implementation of a set of recommendations and a roadmap developed in the "Strengthening Public Health and Community Based Organization (CBO)" Interface report.

To support the introduction of a change in Burkina Faso’s infant pneumococcal vaccine schedule to include a booster dose and to evaluate the impact of the country’s capacity to control pneumococcal disease among children and adults.

To improve use of antibiotics in outpatient settings, where most prescribing occurs, by providing antibiotic stewardship resources for state health departments and state Medicaid agencies.

To evaluate the impact of a pneumococcal conjugate vaccine schedule change in Mozambique on vaccine-type pneumococcal carriage and invasive pneumococcal disease; and serotype 1 colonization among patients with suspected pneumonia and serotype 1 disease among children and adults.

To support efforts to strengthen and expand existing infection prevention control activities in various countries across Sub-Saharan Africa.

To provide laboratory support for the analysis of immunogenicity and shedding of new oral Poliovirus vaccines in human clinical trials and related issues for polio endgame.

To ensure impact and effectiveness of rotavirus vaccines and sustain vaccine use by policy makers, physicians and parents to increase the speed of adoption of vaccine by other countries in Africa and around the world.

To develop cell culture and small animal models of Nipah virus replication and pathogenesis in a biosafety level (BSL) 4 lab.

To investigate long-acting PrEP formulations in macaque subjects.

To engage partners and stakeholders on awareness and education for infection associated chronic conditions (IACC).

To engage communities through the power of arts and culture to educate, empower and mobilize individuals toward positive change. Thriving Together Atlanta serves as a model of how cross-sector partnerships can address multifaceted issues affecting communities today.

To build community resilience against weather events by supporting local disaster preparedness programs through community-based organizations in the Midwest, with a focus on rural areas.